uniQure
QURE
#5383
Rank
A$2.04 B
Marketcap
A$32.76
Share price
2.06%
Change (1 day)
187.24%
Change (1 year)

uniQure (QURE) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$0.99 Billion

According to uniQure's latest financial reports the company's total liabilities are A$0.99 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

uniQure - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$0.90 B-1.13%
2023-12-31A$0.91 B172.23%
2022-12-31A$0.33 B14.3%
2021-12-31A$0.29 B134.57%
2020-12-31A$0.12 B-30.03%
2019-12-31A$0.17 B33.99%
2018-12-31A$0.13 B-13.12%
2017-12-31A$0.15 B-12.3%
2016-12-31A$0.17 B-5.01%
2015-12-31A$0.18 B136.19%
2014-12-31A$78.3 M51.42%
2013-12-31A$51.71 M575.58%
2012-12-31A$7.65 M-27.88%
2011-12-31A$10.61 M-10.36%
2010-12-31A$11.84 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
A$121.18 B 12,107.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
A$0.12 B-87.51%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
A$0.53 B-46.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
A$0.37 B-62.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$99.37 B 9,909.63%๐Ÿ‡ซ๐Ÿ‡ท France
BioMarin Pharmaceutical
BMRN
A$2.34 B 136.22%๐Ÿ‡บ๐Ÿ‡ธ USA